BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Compendia Bioscience Awarded $1.3 Million in SBIR Fast Track Funds


8/31/2010 10:09:38 AM

Ann Arbor, Mich. (August 31, 2010) — Compendia Bioscience, Inc. today announced the award of $1.3 million in SBIR Fast Track funds to incorporate micro-RNA data and analyses into the Oncomine platform.

Despite the growing accumulation of micro-RNA profiling data in a range of cancer-related studies, it is nearly impossible for a cancer biologist to survey the differential expression of an individual micro-RNA or micro-RNA signature across all published datasets, or to integrate knowledge about micro-RNA expression patterns with other relevant biological phenomena such as gene expression, copy number, and mutation data.

This project will systematically capture, curate, and analyze the novel micro-RNA data type in a standardized way and provide the data and analyses in an interface that promotes ongoing inquiry. This effort will require significant technical innovation to capture, organize, and present data that is both biologically and technically complex in a way that is rapidly comprehensible to the cancer biologist.

For additional information regarding this announcement, please contact:

John Freshley Chief Business Officer, Compendia Bioscience Phone: (734) 945-6344 E-mail: media@compendiabio.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES